Читать книгу Pathy's Principles and Practice of Geriatric Medicine - Группа авторов - Страница 564

1 1. Nutritional anaemias. Report of a WHO scientific group. Geneva, World Health Organization, 1968. WHO Technical Report Series, No. 405. Accessed 24 December 2019. http://whqlibdoc.who.int/trs/WHO_TRS_405.pdf.

2 2. Wouters HJCM, van der Klauw MM, de Witte T, et al. Association of anaemia with health‐related quality of life and survival: a large population‐based cohort study. Haematologica. 2019; 104(3):468‐76.

3 3. Den Elzen WP, Willems JM, Westendorp RG, et al. Effect of anemia and comorbidity on functional status and mortality in old age: results from the Leiden 85‐plus study. CMAJ. 2009; 181:151‐57.

4 4. Balducci L. Anemia, fatigue and aging. Transfus Clin Biol. 2010; 17:375‐81.

5 5. Ruan Y, Guo Y, Kowal P, et al. Association between anemia and frailty in 13,175 community‐dwelling adults aged 50 years and older in China. BMC Geriatr. 2019; 19(1):327. Doi: 10.1186/s12877‐01901342‐5.

6 6. Qin T, Yan M, Fu Z, et al. Association between anemia and cognitive decline among Chinese middle‐aged and elderly: evidence from the China health and retirement longitudinal study. BMC Geriatr. 2019; 19(1):305. Doi: 10.1186/s12877‐01901308‐7.

7 7. Valderrabano RJ, Lee J, Lui LY, et al. Older men with anemia have increased fracture risk independent of bone mineral density. J Clin Endocrinol Metab. 2017; 102(7):2199‐2206.

8 8. Culleton BF, Manns BJ, Zhang J, et al. Impact of anemia on hospitalization and mortality in older adults. Blood. 2006; 107(10):3841‐46.

9 9. Riva E, Tettamanti M, Mosconi P, et al. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population‐based study. Haematologica. 2009; 94(1):22‐28.

10 10. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in person 65 years and older in the United States: evidence of a high rate of unexplained anemia. Blood. 2004; 104(8):2263‐68.

11 11. Gaskell H, Derry S, Andrew Moore R, et al. Prevalence of anaemia in older persons: systematic review. BMC Geriatr. 2008; 8:1.Doi:10.1186/1471‐2318‐8‐1.

12 12. Stauder R, Thein SL. Anemia in the elderly: clinical implications and new therapeutic concepts. Haematologica. 2014; 99(7):1127‐30.

13 13. Bach V, Schruckmayer G, Sam I, et al. Prevalence and possible causes of anemia in the elderly: a cross‐sectional analysis of a large European university hospital cohort. Clin Interv Aging. 2014; 9:1187‐96.

14 14. Johnson‐Wimbley TD, Graham DY. Diagnosis and management of iron deficiency anemia in the 21st century. Therap Adv Gastroenterol. 2011; 4(3):177‐84.

15 15. Sanford AM. Anorexia of aging and its role for frailty. Curr Opin Clin Nutr Metab Care. 2017; 20(1):54‐60.

16 16. Sarzynski E, Puttarajappa C, Xie Y, et al. Association between proton pump inhibitor use and anemia: a retrospective cohort study. Dig Dis Sc. 2011; 56(8):2349‐53.

17 17. Abbaspour N, Hurrell R, and Kelishadi R. Review on iron and its importance for human health. J Res Med Sci. 2014; 19(2):164‐74.

18 18. Bunn HF, Heeney MM. Pathophysiology of Blood Disorders. 2011. Accessed 1 Jan 2020. https://accessmedicine.mhmedical.com/content.aspx?bookid=1900&sectionid=137394788.

19 19. Ioannou G, Spector J, Scott K, et al. Prospective evaluation of a clinical guideline for the diagnosis and management of iron deficiency anemia. Am J Med. 2002; 113(4):281‐287.

20 20. Mast A, Blinder M, Gronowski A, et al. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem. 1998; 44(1):45‐51.

21 21. Short MW, Domagalski JE. Iron deficiency anemia: evaluation and management. Am Fam Physician. 2013; 87(2):98‐104.

22 22. O’Neil‐cutting M, Crosby W. Blocking of iron absorption by a preliminary oral dose of iron. Arch Intern Med. 1987; 147(3):489‐91

23 23. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low‐dose iron therapy is effective in octogenarians. Am J Med. 2005; 118:1142‐47.

24 24. Hurrell RF, Reddy M, Cook JD. Inhibition of non‐haem iron absorption in man by polyphenolic‐containing beverages. Br J Nutr. 1999: 81:289‐95.

25 25. Morck TA, Cook JD. Factors affecting the bioavailability of dietary iron. Cereal Food World. 1981; 26(12):667‐72.

26 26. Liu K, Kaffes AJ. Iron deficiency anemia: a review of diagnosis, investigation, and management. Eur J Gastroenterol Hepatol. 2012; 24(2):109‐16.

27 27. Ioannou GN, Rockey DC, Bryson CL, et al. Iron deficiency and gastrointestinal malignancy: a population‐based cohort study. Am J Med. 2002; 113(4):276‐80.

28 28. Love AL, Billett HH. Obesity, bariatric surgery, and iron deficiency: true, true, true and related. Am J Hematol. 2008; 83(5):403‐9.

29 29. Baik H, Russell R. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999; 19:357‐77.

30 30. Lindenbaum J, Rosenberg IH, Wilson PW et al. Prevalence of cobalamin deficiency in the Gramingham elderly population. Am J Clin Nutr. 1994; 60:2‐11.

31 31. Clarke R, Grimley EValns, J, Schneede J, et al. Vitamin B12 and folate deficiency in later life. Age Ageing. 2004; 33:34‐41.

32 32. Pfisterer K, Sharratt M, Heckman G, et al. Vitamin B12 status in older adults living in Ontario long‐term care homes: prevalence and incidence of deficiency with supplementation as a protective factor. Appl physiol Nutr Metab. 2016; 41(2):219‐22.

33 33. De Jager J, Kooy A, Lehert P, et al. Long‐term treatment with metformin in patients with type 2 diabetes and risk of vitamin B12 deficiency: randomized placebo‐controlled trial. BMJ. 2010; 340:c2181.

34 34. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med. 2000; 51:357‐75.

35 35. Loukili NH, Noel E, Blaison G, et al. Update of pernicious anemia: a retrospective study of 49 cases. Rev Med Interne. 2004; 25:556‐61.

36 36. Nagao T, Hirokawa M. Diagnosis and treatment of macrocytic anemias in adults. J Gen Fam Med. 2017; 18(5):200‐204.

37 37. Savage DG, Lindenbaum J, Stabler SP, et al. Sensitvitiy of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med. 1994; 96(3):239‐46.

38 38. Langan R, Zawistoski K. Update on Vitamin B12 Deficiency. Am Fam Physician. 2011; 83(12):1425‐30.

39 39. Wong CW. Vitamin B12 deficiency in the elderly: is it worth screening? Hong Kong Med J. 20015; 21:155‐64.

40 40. Carmel R. Green R, Rosenblatt DS, et al. Update on cobalamin, folate, and homocysteine. Hematology Am Soc Hematol Educ Program. 2003:62‐81.

41 41. Carmel R. Cobalamin, the stomach, and aging. Am J Clin Nutr. 1997; 66:750‐9.

42 42. Vidal‐Alaball J, Butler C, Cannings‐John R, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cocahrane Database Syst Rev. 2005;(3):CD004655.

43 43. US Department of Health and Human Services Food and Drug Administration. Food standards: amendment of the standards of identity for enriched grain product to require addition of folic acid. Fed Regist. 1996; 61:8781.

44 44. Sanford AM, Flaherty JH. Do nutrients play a role in delirium? Curr Opin Clin Nutr Metab Care. 2014; 17(1):45‐50.

45 45. Khan KM, Jialal I. Folic Acid (Folate) Deficiency. StatPearls Publishing; 2020.

46 46. Scott J, Weir D. Folate/vitamin B12 inter‐relationshiprs. Essays Biochem. 1994; 28:63‐72.

47 47. Sobczynska‐Malefora A, Harrington D. Laboratory assessment of folate (vitamin B9 status). J Clin Path. 2018; 71(11):949‐56.

48 48. Joosten E, Lioen P. Iron deficiency anemia and anemia of chronic disease in geriatric hospitalized patients: how frequent are comorbidities as an additional explanation for the anemia? Geriatr Gerontol Int. 2014; 15(8):931‐5.

49 49. Careaga M, Moize V, Flores L, et al. Inflammation and iron status in bariatric surgery candidates. Surg Obes Relat Dis. 2015; 11(4):906‐11.

50 50. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver Physiol. 2002; 282:G403‐414.

51 51. Nemeth E, Rivera S, Gabayan V, et al. IL‐6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113:1271‐6.

52 52. Jelkmann W. Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res. 1998; 18:555‐9.

53 53. Moldawer LL, Marano MA, Wei H, et al. Cachectin/tumor necrosis factor‐alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J. 1989; 3:1637‐43.

54 54. Maciejewski JP, Selleri C, Sato T, et al. Nitric oxide suppression of human hematopoiesis in vitro: contribution to inhibitory action of interferon‐gamma and tumor necrosis factor‐alpha. J Clin Invest. 1995; 96:1085‐92.

55 55. Skikne BS, Punnonen K, Caldron PH, et al. Improved differential diagnosis of anemia of chronic disease and iron deficiency anemia: a prospective multicenter evaluation of soluble transferrin receptor and the sTfR/log ferritin index. Am J Hematol. 2011; 86(11):923‐27.

56 56. Weiss G. Iron and immunity: a double‐edged sword. Eur J Clin Invest. 2002; 32:Supple 1 70‐80.

57 57. Kletzmayr J, Sunder‐Plassmann G, Horl WH. High dose intravenous iron: a note of caustion. Nephrol Dial transplant. 2002; 17:962‐5.

58 58. Weiss G, Goodnough L. Anemia of chronic disease. N Engl J Med. 2005; 352:1011‐23.

59 59. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 203; 49:1573‐8.

60 60. Rizzo JD, Lichtin AE, Woolf SH, et al. Use of epoetin in patients with cancer: evidence‐based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol. 2002; 20:4083‐4107.

61 61. National Kidney Foundation. KEEP 2004 annual data report. Am J Kidney Dis. 2005; 45(suppl 2):S1‐80.

62 62. McClellan W, Resnick B, Lei L, et al. Prevalence and severity of chronic kidney disease and anemia in the nursing home population. J Am Med Dir Assoc. 2010; 11:33‐41.

63 63. Ma JZ, Ebben J, Xia H, et al. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol. 1999; 10:610‐9.

64 64. Moreno F, Sanz‐Guajardo D, Lopez‐Gomez, JM, et al. Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients: Spanish Cooperative Renal Patients Quality of Life Study Group of the Spanish Society of Nephrology. J Am Soc Nephrol. 2000: 11:335‐42.

65 65. Besarab A, Ayyoub F. Anemia in renal disease: Diseases of the Kidney and Urinary Tract, 8th ed. Lippincott Williams and Wilkins; 2007:2406–2430.

66 66. Hunsicker L, Levey A. Progression of chronic renal disease: mechanisms, risk factors, and testing of interventions. The Principles and Practice of Nephrology. Mosby; 1995:622‐31.

67 67. Anapalahan M, Savvas S, Lo K, et al. Chronic idiopathic normocytic anaemia in older people: the risk factors and the role of age‐associated renal impairment. Aging Clin Exp Res. 2017; 29:147‐55.

68 68. Nielson O, Thayson J. Erythropoietin deficiency in acute renal failure. Lancet. 1989; 1:634‐5.

69 69. Cotes PM, Tam RC, Reed P, et al. An immunological cross‐reactant of erythropoietin in serum which may invalidate EPO radioimmunoassay. BR J Haematol. 1989; 73:265‐68.

70 70. NKF‐K/DOQI Clinical Practice Guidelines for anemia of chronic kidney disease: update 2000. Am J Kidney Dis. 2001: 37:Suppl 1:S182–S238.

71 71. Phrommintikul A, Haas SJ, Elsik M, et al. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta‐analysis. Lancet. 2007; 369:381‐88.

72 72. KDOQI, National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006; 47(5 Supple 3):S11‐145.

73 73. Bennett CL, Becker PS, Kraut EH et al. Intersecting guidelines: administering erythropoiesis‐stimulating agents to chronic kidney disease patients with cancer. Semin Dial. 2009; 22:1‐4.